Tempest Therapeutics Inc. Revenue 2013–2017
Tempest Therapeutics Inc. annual/quarterly revenue history and growth rate from 2013 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tempest Therapeutics Inc. revenue for the quarter ending September 30, 2018 was 55000, a 1.79% decrease year-over-year.
- Tempest Therapeutics Inc. revenue for the twelve months ending September 30, 2018 was 259000, a 51.41% decrease year-over-year.
- Tempest Therapeutics Inc. annual revenue for 2017 was 295000, a 54.82% decrease from 2016.
- Tempest Therapeutics Inc. annual revenue for 2016 was 653000, a 135.74% increase from 2015.
- Tempest Therapeutics Inc. annual revenue for 2015 was 277000.
- Tempest Therapeutics Inc. annual revenue for 2014 was 0.
Tempest Therapeutics Inc. (TPST) — Frequently Asked Questions
Tempest Therapeutics Inc. (TPST) is a publicly traded US company. It has a market capitalization of $312,860.69. In fiscal 2017 it reported revenue of $295,000 and net income of -$85M. Explore TPST's stock price, financial statements, earnings history, margins and key ratios below.
What is Tempest Therapeutics Inc.'s market cap?
Tempest Therapeutics Inc. (TPST) has a market capitalization of $312,860.69.
What is the TPST stock price?
TPST trades at $1.27.
How much revenue does Tempest Therapeutics Inc. make?
Tempest Therapeutics Inc. reported revenue of $295,000 in fiscal 2017.
Is TPST profitable?
In fiscal 2017, Tempest Therapeutics Inc. reported net income of -$85M.